Brain-derived neurotrophic factor: findings in schizophrenia
Authors:
- Peter F BuckleyPBPeter F Buckley
- Anilkumar PillaiAPAnilkumar Pillai
- Kristy R HowellKHKristy R Howell
- 1 March 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 24 (2) , 122-127
Abstract
To review the role of brain-derived neurotrophic factor (BDNF) in neuroplasticity related to schizophrenia and the recent findings that have been reported on the status of BDNF in patients with schizophrenia and its association with the clinical measures. Peripheral BDNF levels have been found altered in first-episode patients with psychosis and also in chronic schizophrenia patients. A few studies have reported changes in peripheral BDNF levels following antipsychotic treatment. The role of Val66Met polymorphism in BDNF has been shown to play an important role in structural and functional plasticity in schizophrenia. Although peripheral BDNF levels hold promise for providing new perspectives for the development of novel therapeutic strategies for the treatment of schizophrenia, additional studies including efforts to prove its potential as a biomarker are warranted.Keywords
This publication has 89 references indexed in Scilit:
- Decreased BDNF in patients with antipsychotic naïve first episode schizophreniaSchizophrenia Research, 2010
- Calcium signaling cascade links dopamine D1–D2 receptor heteromer to striatal BDNF production and neuronal growthProceedings of the National Academy of Sciences, 2009
- New insights into the role of brain-derived neurotrophic factor in synaptic plasticityMolecular and Cellular Neuroscience, 2009
- Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expressionNeuroReport, 2009
- BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?Neurobiology of Learning and Memory, 2008
- Brain-Derived Neurotropic Factor/TrkB Signaling in the Pathogenesis and Novel Pharmacotherapy of SchizophreniaNeurosignals, 2008
- Brain derived neurotropic factor in first-episode psychosisSchizophrenia Research, 2007
- Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related BehaviorScience, 2006
- The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2006
- Cognitive and Magnetic Resonance Imaging Brain Morphometric Correlates of Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism in Patients With Schizophrenia and Healthy VolunteersArchives of General Psychiatry, 2006